892 ABL503 (TJ-L14B), PD-L1x4–1BB bispecific antibody induces superior anti-tumor activity by PD-L1-dependent 4–1BB activation with the increase of 4–1BB+CD8+ T cells in tumor microenvironment

Схожі ресурси

• 892 ABL503 (TJ-L14B), PD-L1x4–1BB bispecific antibody induces superior anti-tumor activity by PD-L1-dependent 4–1BB activation with the increase of 4–1BB+CD8+ T cells in tumor microenvironment
  за авторством: Wenqing Jiang, та інші
  Опубліковано: (2021-11-01)
• Novel anti-4-1BB×PD-L1 bispecific antibody augments anti-tumor immunity through tumor-directed T-cell activation and checkpoint blockade
  за авторством: Lei Fang, та інші
  Опубліковано: (2021-07-01)
• 4-1BB co-stimulation further enhances anti-PD-1-mediated reinvigoration of exhausted CD39+ CD8 T cells from primary and metastatic sites of epithelial ovarian cancers
  за авторством: SungHoon Kim, та інші
  Опубліковано: (2020-10-01)
• 859 Inhibition of the kinase activity of hematopoietic progenitor kinase 1 enhances anti-PD-1-induced reinvigoration of human tumor-infiltrating CD8+ T cells
  за авторством: Yongjoon Lee, та інші
  Опубліковано: (2020-11-01)
• Peptide Blockers of PD-1-PD-L1 Interaction Reinvigorate PD-1-Suppressed T Cells and Curb Tumor Growth in Mice
  за авторством: Shanshan (Jenny) Zhong, та інші
  Опубліковано: (2024-07-01)